Making Medicine
By Incubate Coalition
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Incubate Coalition
Category: Health & Fitness
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 77
Description
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
| Episode | Date |
|---|---|
|
FDA Leadership After Marty Makary: What Biotech Needs Next
|
May 14, 2026 |
|
FDA Approvals Corner, Immigration Warnings & Germany's MFN Complication | Making Medicine Headlines
|
May 07, 2026 |
|
Senator Todd Young on China, FDA Reform, and Why Biotech Is National Security
|
Apr 30, 2026 |
|
FDA Instability Is Changing Biotech Investment—What Investors Are Saying
|
Apr 23, 2026 |
|
FDA Signals Are Breaking Biotech | Collapse, Breakthrough, and What Congress Does Next
|
Apr 16, 2026 |
|
Tariffs, MFN & FDA Delays: Why Biotech Is at Risk
|
Apr 09, 2026 |
|
The China Biotech Threat Is Already Here | John Gutierrez on Capitol Hill, Drug Pricing & FDA
|
Apr 02, 2026 |
|
Biotech, National Security, and Global Competition | Dr. Rozo (NSCEB) | JPM Re-Air
|
Mar 26, 2026 |
|
Solving Japan's Drug Lag: Why PM Takaichi Must Agree to a Fair U.S. Pricing Deal
|
Mar 19, 2026 |
|
Regulatory Risk: How FDA Instability Is Threatening America's Biotech Investment Edge
|
Mar 12, 2026 |
|
China Just Passed the U.S. in Drug Clinical Trials
|
Mar 05, 2026 |
|
Why 95% of Rare Diseases Still Have No Treatment
|
Feb 26, 2026 |
|
FDA Chaos and Foreign Price Controls Are Collapsing American Innovation
|
Feb 19, 2026 |
|
TrumpRx Explained: Cash Markets, MFN, and What This Moment Means for Drug Pricing
|
Feb 12, 2026 |
|
Speed, Scrutiny, and Spending: How Washington Is Reshaping the Future of Medicine
|
Feb 05, 2026 |
|
Live From JPM 2026: Is This the End of American Biotech Leadership?
|
Jan 29, 2026 |
|
How Global Competition and U.S. Policy Choices Are Reshaping Biotech | Live at JPM 2026 (Part 2)
|
Jan 22, 2026 |
|
Innovation at a Crossroads | Live at JPM 2026 (Part 1)
|
Jan 15, 2026 |
|
CMS Drug Pricing Proposals and What JPM 2026 Signals
|
Jan 08, 2026 |
|
How Policy Shapes the Future of Life Sciences
|
Jan 01, 2026 |
|
Year in Review: Biotech Innovation, Policy, and Global Competition
|
Dec 25, 2025 |
|
Biotech in 2025: Investment Trends, Congress, and Approvals
|
Dec 18, 2025 |
|
What the NDAA Means for the Future of Biotech
|
Dec 11, 2025 |
|
Inside Congress: Senator Thom Tillis on Drug Pricing, IP, and the Future of Innovation
|
Dec 04, 2025 |
|
Making Medicine ft. Daphne Zohar. Biotech Flywheels, Policy Risks, and the Future of Innovation
|
Nov 25, 2025 |
|
Japan’s Life Sciences State of Play: The Takeaways You Can’t Miss
|
Nov 20, 2025 |
|
Inside Biotech Leadership: Bill Newell on Innovation, Capital, and Policy at Sutro Biopharma
|
Nov 13, 2025 |
|
U.S. Biomanufacturing Surge, Arena BioWorks Fallout & GLP-1 Rumors | Making Medicine Podcast
|
Nov 06, 2025 |
|
Is the U.S. Losing Its Biotech Edge to China? Senate Hearing & Innovation Outlook
|
Oct 30, 2025 |
|
FDA Vouchers, Orphan Cures & IP with Joshua Kresh
|
Oct 23, 2025 |
|
Shutdown Fallout, MFN Deals & BIOSECURE Returns
|
Oct 16, 2025 |
|
Boston Biotech Pulse: Shutdowns, Pfizer Deal, and the Future of Innovation
|
Oct 09, 2025 |
|
Government Shutdown, SBIR Expiration, and Trump’s Pharma Moves | Making Medicine Podcast
|
Oct 02, 2025 |
|
China’s Biotech Surge, GLP-1 Prices, & MFN Deadline | Press Pass with Max Bayer
|
Sep 25, 2025 |
|
UK Pharma Challenges, DTC Ads Debate & 5 New FDA Approvals | Making Medicine
|
Sep 18, 2025 |
|
Ending the Pill Penalty on 9/13, Tariffs & FDA Rare Disease Guidance | Making Medicine
|
Sep 11, 2025 |
|
MassBio’s 2025 Snapshot: VC Gravity, Policy & a Competitiveness Playbook | Kendalle Burlin O’Connell
|
Sep 04, 2025 |
|
Trump’s Tariffs, NIH Cuts, FDA Approvals & SBIR Debate | This Week in Making Medicine
|
Aug 28, 2025 |
|
Ned Sharpless on Biotech’s Future, HHS Shifts, and Global Competition | Making Medicine Podcast
|
Aug 21, 2025 |
|
FDA Shake-Ups & mRNA Funding Cuts | Industry Perspectives with Patrick Jordan
|
Aug 14, 2025 |
|
President Trump’s “Most Favored Nation” Drug Pricing Plan: Good Deal or Dangerous Gamble?
|
Aug 07, 2025 |
|
Listener Q&A: Drug Price Controls, EU Tariffs, and the August Recess | Making Medicine Podcast
|
Jul 31, 2025 |
|
Unpacking Uncertainty: Trump’s Health Policies & Future of FDA | Press Pass with Nyah Phengsitthy
|
Jul 24, 2025 |
|
Trump’s 200% Pharma Tariff? Timeline, Impacts, and What Comes Next | Making Medicine Podcast
|
Jul 17, 2025 |
|
Big Beautiful Bill Breakdown, Orphan Cures Win, and What’s Next | Making Medicine Podcast Relaunch
|
Jul 10, 2025 |
|
When Progress Gets Penalized: Biotech in the Age of IRA
|
Apr 18, 2025 |
|
Bridging Science and Business: A Conversation with Professor Fred Ledley
|
Feb 13, 2025 |
|
Can We Fix Healthcare? A Look Inside Our System
|
Oct 15, 2024 |
|
Protecting Innovation: Small Molecules and the Future of Medicine
|
Sep 13, 2024 |
|
CEO Series Part 1: Sherine Chan, CEO & Co-founder of Neuroene Therapeutics
|
Jun 28, 2024 |
|
Dispelling Misconceptions in Biopharmaceutical IP Regulation
|
May 03, 2024 |
|
When the Feds Come Marching In: A Deep Dive on The Bayh-Dole Act
|
Apr 11, 2024 |
|
Beyond Medicine: Solving Disparities in Cancer Care
|
Sep 13, 2023 |
|
Balancing Access and Affordability in the Future of Healthcare
|
Aug 23, 2023 |
|
Making Patients the Center of U.S. Healthcare Reform
|
May 11, 2023 |
|
Innovations in Women’s Health & Entrepreneurship
|
Mar 31, 2023 |
|
The Inflation Reduction Act: A Big Issue for Small-Molecule Medicine
|
Mar 24, 2023 |
|
From the JP Morgan Conference: The Impact of the Inflation Reduction Act
|
Jan 23, 2023 |
|
Drug Investment Under the Inflation Reduction Act
|
Dec 12, 2022 |
|
The Three Pillars of Bio & Med Tech Investing and Industry Impact of DEI
|
Sep 28, 2022 |
|
Understanding Health Equity w/ Dr. Jerome Adams
|
Jul 19, 2022 |
|
Addressing The Overlooked AMR Problem w/ Dr. Henry Skinner
|
May 24, 2022 |
|
Pro-Patient Reforms: The Outlook for 2022
|
Apr 19, 2022 |
|
How Better Data Fosters Health Equity w/ Kirsten Axelsen
|
Apr 05, 2022 |
|
Winning the Drug Development Relay Race w/ Johannes Fruehauf
|
Feb 11, 2022 |
|
New Modalities: The Future of Drug Development w/ Jean-Francois Formela
|
Dec 21, 2021 |
|
The Investor’s Paradox, Drug Development, & Price Controls w/ Peter Kolchinsky
|
Nov 02, 2021 |
|
MIT Takeover: A MedTech-VC Partnership Working to Reduce Parkinson’s Tremors
|
Oct 19, 2021 |
|
Venture Capital Investors: The Underwriters of Innovation w/ Janis Naeve, Brian Bradbury, and Alan Brookhart
|
Sep 28, 2021 |
|
The Hidden Cost of Price Control Policies w/ Kirsten Axelsen
|
Sep 14, 2021 |
|
You Cannot Make Medicine Alone: Relationships & Mentoring w/ Imran Nasrullah
|
Jul 27, 2021 |
|
Improving the Standard of Care w/ Patients in Mind
|
Jul 13, 2021 |
|
The Truth About Pharmaceuticals w/ Ravi Mehrotra
|
Jun 29, 2021 |
|
Valuing Inventors & Entrepreneurs: Changing the Dialogue of IP w/ Andrei Iancu
|
Jun 15, 2021 |
|
AMR: Challenges and Insight w/ Alfonso Chang
|
May 31, 2021 |
|
40 Years in Review: Bayh-Dole to 2021 w/ Joe Allen
|
May 15, 2021 |
|
Making Medicine: An Origin Story
|
May 15, 2021 |